54gene Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Employees
-
200
- Latest Deal Type
-
Out of Business
54gene General Information
Description
Operator of a genetic testing platform intended to improve the understanding of the human genome. The company's platform provides genetic testing and molecular diagnostics services to patients and physicians and is compliant with international data privacy laws, enabling the healthcare industry to carry out academic research and improve access to life-saving diagnostics.
Contact Information
Website
www.54gene.comCorporate Office
- 1100 Fifteenth Street NorthWest
- Washington, DC 20005
- United States
Corporate Office
- 1100 Fifteenth Street NorthWest
- Washington, DC 20005
- United States
54gene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Out of Business | 27-Sep-2023 | Completed | Out of Business | |||
| 7. Early Stage VC (Series B) | 17-May-2022 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | 01-Jan-2022 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 01-Mar-2020 | Completed | Generating Revenue | |||
| 3. Seed Round | 03-Jul-2019 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Apr-2019 | $150K | Completed | Startup | ||
| 1. Accelerator/Incubator | 13-Mar-2019 | $150K | $150K | Completed | Startup |
54gene Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-7 | ||||||||
| Series A-6 | ||||||||
| Series A-5 | ||||||||
| Series A-4 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Series A | 11,833,349 | $0.000010 | $1.34 | $1.34 | 1x | $1.34 | 30% | |
| Seed | 1,240,943 | $0.000010 | $1 | $1 | 1x | $1 | 3.15% |
54gene Comparisons
Industry
Financing
Details
54gene Competitors (21)
One of 54gene’s 21 competitors is Agendia, a Venture Capital-Backed company based in Irvine, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Agendia | Venture Capital-Backed | Irvine, CA | ||||
| OncoLens | Venture Capital-Backed | Atlanta, GA | ||||
| Biodesix | Formerly VC-backed | Louisville, CO | ||||
| NeoGenomics | Corporation | Fort Myers, FL | ||||
| Futura Genetics | Venture Capital-Backed | Petah Tikva, Israel |
54gene Signals
54gene FAQs
-
When was 54gene founded?
54gene was founded in 2019.
-
Where is 54gene headquartered?
54gene is headquartered in Washington, DC.
-
What is the size of 54gene?
54gene has 200 total employees.
-
What industry is 54gene in?
54gene’s primary industry is Other Healthcare Technology Systems.
-
Is 54gene a private or public company?
54gene is a Private company.
-
What is 54gene’s current revenue?
The current revenue for 54gene is .
-
How much funding has 54gene raised over time?
54gene has raised $46.3M.
-
Who are 54gene’s competitors?
Agendia, OncoLens, Biodesix, NeoGenomics, and Futura Genetics are some of the 21 competitors of 54gene.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process